| 31.47 3.83 (13.86%) | 06-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 37.23 |
1-year : | 43.49 |
| Resists | First : | 31.87 |
Second : | 37.23 |
| Pivot price | 28.05 |
|||
| Supports | First : | 26.56 |
Second : | 23.28 |
| MAs | MA(5) : | 27.93 |
MA(20) : | 27.6 |
| MA(100) : | 23.03 |
MA(250) : | 21.19 |
|
| MACD | MACD : | 1.1 |
Signal : | 1.2  |
| %K %D | K(14,3) : | 57.5 |
D(3) : | 45.2 |
| RSI | RSI(14): 71.5 |
|||
| 52-week | High : | 31.87 | Low : | 10.17 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ELIL ] has closed above the upper band by 18.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 6.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31.9 - 31.99 | 31.99 - 32.1 |
| Low: | 27.51 - 27.62 | 27.62 - 27.73 |
| Close: | 31.27 - 31.44 | 31.44 - 31.64 |
The Direxion Daily LLY Bull 2X ETF is engineered to deliver daily investment results that are twice (200%) the performance of Eli Lilly and Company's (LLY) common shares. Conversely, the Direxion Daily LLY Bear 1X ETF endeavors to provide daily returns equal to the inverse (opposite) of LLY's share performance, at a 100% ratio. Both ETFs pursue these objectives before factoring in any fees or operational expenses.
Fri, 01 May 2026
With Earnings Booming, Can Lilly Hold Its Pharma Crown? - Moomoo
Wed, 22 Apr 2026
Volatility Meets Earnings Season – Q1 2026 - Direxion
Thu, 08 Jan 2026
Q4 Earnings: Beat, Miss, or Market Whiplash? - Direxion
Tue, 30 Sep 2025
TBXU: Biotech Top 5 Bull 2X ETF - Direxion
Thu, 11 Sep 2025
Leveraged ETFs: Single-Stock Surge - ETF Trends
Mon, 11 Aug 2025
Are More Challenges Ahead for Eli Lilly After Earnings Beat? - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Leveraged
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|